JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Eugenio Pompeo
Vincenzo Ambrogi
Tommaso Claudio Mineo
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pompeo, E.
Right arrow Articles by Mineo, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pompeo, E.
Right arrow Articles by Mineo, T. C.
Related Collections
Right arrow Lung - other

J Thorac Cardiovasc Surg 2004;127:1212-1214
© 2004 The American Association for Thoracic Surgery

Brief communication

Completion lobectomy after bilateral lung volume reduction for emphysema: Salvage option or fancy?

Eugenio Pompeo, MDa, Davide Mineo, MDa, Patrizio Bollero, MDa, Paola Rogliani, MDa, Vincenzo Ambrogi, MDa, Tommaso Claudio Mineo, MDa,*

a Thoracic Surger and the Multidisciplinary Pulmonary Program, Policlinico University Tor Vergata, Rome, Italy

Received for publication August 1, 2003; revisions received October 2, 2003; revisions received November 3, 2003; accepted for publication December 3, 2003.

* Address for reprints: Tommaso C. Mineo, MD, Cattedra di Chirurgia Toracica, Università Tor Vergata, Policlinico Tor Vergata, V.le Oxford 81 00133 Rome, Italy
mineo{at}med.uniroma2.it


Ambrogi, Bollero, Pompeo, TC Mineo, Rogliani, D Mineo


Bilateral lung volume reduction (LVR) can significantly improve the functional capacity of selected patients with severe emphysema and an upper-lobe predominance of disease.1,2 However, because of its palliative nature, postoperative improvements usually peak within the first 6 months and slowly decline subsequently, eventually returning back to the baseline status in most patients. Little is known, however, as to whether redo LVR3 can be reasonably proposed in selected patients after bilateral LVR.

Herein we describe 4 patients with upper-lobe prevailing emphysema who underwent completion lobectomy (CL) as a redo LVR after a previous bilateral operation. The patients, all men, were operated on between September 2001 and October 2002. All patients gave their written, informed consent. The mean interval between bilateral LVR and CL was 59 months. After the bilateral operation, marked improvements occurred in pulmonary function measures: +360 mL in forced expiratory volume in 1 second (FEV1), –1170 mL in residual volume, +125 m in the 6-minute walking test, and +5.25 mm Hg in arterial oxygen tension. Afterward, the FEV1 annual decline averaged 0.23 ± 0.09 L at 24 months and ±0.08 L at 36 months.

CL was performed when FEV1 returned to baseline values and high-resolution computed tomography showed severe emphysematous lung destruction that was prevailing in 1 upper lobe (Figure 1, 1 and 2). Before CL, all patients were receiving maximized medical therapy and underwent a 4-week respiratory rehabilitation program.



View larger version (131K):
[in this window]
[in a new window]
  		Figure 1. High-resolution computed tomography of a patient who underwent CL after previous bilateral LVR. Before surgery (1 and 2), a completely destroyed and hyperinflated right upper lobe was shown; after surgery (3 and 4), a meaningful reduction in the overall lung volume occurred in both lungs after right upper CL.

 
CL (3 right upper lobectomies and 1 left upper lobectomy) was performed by video-assisted minithoracotomy (2 patients) or lateral thoracotomy (2 patients). In 2 instances, isolation of the hilar structures was accomplished in a standard manner. In another 2 patients, the fissure was not dissected free, and the upper lobe tissue was excised through nonbuttressed staple resection (Figure 2). All patients were extubated in the operating room, but 1 required early reintubation and eventually died of respiratory failure. In the remaining 3 patients, there were no major complications. The mean in-hospital stay was 11 days. Meaningful improvements occurred in all survivors 6 months after CL, as detailed in Table 1. Right heart catheterization showed no significant changes in pulmonary artery pressure.



View larger version (112K):
[in this window]
[in a new window]
  		Figure 2. Completion lobectomy specimen (right upper lobe) after bilateral LVR.

 

View this table:
[in this window]
[in a new window]
  		TABLE 1. Demographics before and 6 mo after completion lobectomy measures

 
So far, no patient is dead or mechanically ventilated. Severe osteoporosis developed in 1 patient because of prolonged steroid therapy.

This is the first report dealing with redo LVR in patients with cigarette smoking–related severe emphysema and upper lobe predominance. Stammberger and coworkers3 have already reported on a patient with {alpha}1-antytripsin deficiency emphysema, who also benefited from redo LVR.

CL resulted in meaningful functional improvements in 3 of 4 patients, and in no instance did pulmonary hypertension, which can occur after bilateral LVR,4 develop. Nonetheless, 1 patient died of respiratory failure after surgery. We believe that he probably had too-advanced disease in the remaining lung tissue, with a scarcely heterogeneous pattern of emphysema.

Anatomic resection is considered contraindicated in patients with emphysema because of the risk of removal of functioning lung tissue. However, lobectomy has been recently reported5 as a successful LVR procedure in patients with severely emphysematous lung lobes. Despite the very limited cohort, our results suggest that in stringently selected patients with a completely destroyed and functionally useless residual upper lobe, CL can be followed by meaningful improvements in respiratory function measures and exercise capacity.

We advise that CL be strictly performed in patients who have already benefited meaningfully from the first reduction, because it is highly unlikely that a patient who did not benefit from LVR initially will improve after CL. We believe that one reliable way of monitoring the patient's condition is observing the FEV1 decay. In fact, FEV1 is a reliable measure of the severity of chronic obstructive pulmonary disease and is correlated with the clinical benefit of LVR. Our data suggest that FEV1 decay is maximal between 12 and 24 months and becomes less steep subsequently. However, the unavoidable and sometimes accelerated functional decline observed after LVR emphasizes that more efforts must be devoted to improve the current surgical techniques.

We conclude that in carefully selected patients, CL can prolong the benefits of LVR, a surgical option that continues to stimulate active investigation and to raise concerns and skepticism but that can undoubtedly offer some hope to properly selected patients with severe emphysema.

Acknowledgments

This study was performed within the Research Fellowship Program Tecnologie e Terapie Avanzate in Chirurgia awarded by the Tor Vergata University.

Footnotes

This research was supported by Ministero dell’Università e della Ricerca Scientificá e Tecnologica (MURST) Cofinanziamento (COFIN) grants 9906274194-06 and 2001061191-001, Consiglio Nazionale della Ricerca (CNR) CU0100935 2002, and Centro di Eccellenza 2001.

References

  1. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;248:2059–2073
  2. Ciccone AM, Meyers BF, Guthrie TJ, Davis GE, Yusen RD, Lefrak SS, et al. Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema. J Thorac Cardiovasc Surg. 2003;125:513–525[Abstract/Free Full Text]
  3. Stammberger U, Thurnheer R, Schmid RA, Russi EW, Weder W. Redo lung volume reduction surgery in a patient with {alpha}1-antitrypsin deficiency. Ann Thorac Surg. 2000;69:632–633[Abstract/Free Full Text]
  4. Weg IL, Rossoff L, McKeon K, Graver LM, Scharf SM. Development of pulmonary hypertension after lung volume reduction surgery. Am J Respir Crit Care Med. 1999;159:552–556[Abstract/Free Full Text]
  5. Yusen RD, Lefrak SS, Gierada DS, Davis GE, Meyers BF, Patterson GA, et al. A prospective evaluation of lung volume reduction surgery in 200 consecutive patients. Chest. 2003;123:1026–1037[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
F. Tacconi, E. Pompeo, D. Forcella, M. Marino, D. Varvaras, and T. C. Mineo
Lung Volume Reduction Reoperations
Ann. Thorac. Surg., April 1, 2008; 85(4): 1171 - 1177.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Eugenio Pompeo
Vincenzo Ambrogi
Tommaso Claudio Mineo
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pompeo, E.
Right arrow Articles by Mineo, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pompeo, E.
Right arrow Articles by Mineo, T. C.
Related Collections
Right arrow Lung - other

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS